- Home
- SYRE vs SSYS Comparison
SYRE vs SSYS Comparison
Compare SYRE & SSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- SSYS
- Stock Information
- Founded
- SYRE 2013
- SSYS 1989
- Country
- SYRE United States
- SSYS United States
- Employees
- SYRE N/A
- SSYS N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- SSYS Computer peripheral equipment
- Sector
- SYRE Health Care
- SSYS Technology
- Exchange
- SYRE Nasdaq
- SSYS Nasdaq
- Market Cap
- SYRE 1.1B
- SSYS 970.9M
- IPO Year
- SYRE 2016
- SSYS 1994
- Fundamental
- Price
- SYRE $23.71
- SSYS $8.84
- Analyst Decision
- SYRE Strong Buy
- SSYS Strong Buy
- Analyst Count
- SYRE 5
- SSYS 2
- Target Price
- SYRE $55.75
- SSYS $12.75
- AVG Volume (30 Days)
- SYRE 741.8K
- SSYS 1.1M
- Earning Date
- SYRE 11-04-2025
- SSYS 11-13-2025
- Dividend Yield
- SYRE N/A
- SSYS N/A
- EPS Growth
- SYRE N/A
- SSYS N/A
- EPS
- SYRE N/A
- SSYS N/A
- Revenue
- SYRE N/A
- SSYS $561,461,000.00
- Revenue This Year
- SYRE N/A
- SSYS N/A
- Revenue Next Year
- SYRE N/A
- SSYS $3.06
- P/E Ratio
- SYRE N/A
- SSYS N/A
- Revenue Growth
- SYRE N/A
- SSYS N/A
- 52 Week Low
- SYRE $10.91
- SSYS $8.36
- 52 Week High
- SYRE $33.47
- SSYS $12.88
- Technical
- Relative Strength Index (RSI)
- SYRE 60.31
- SSYS 29.10
- Support Level
- SYRE $21.63
- SSYS $9.32
- Resistance Level
- SYRE $24.19
- SSYS $9.92
- Average True Range (ATR)
- SYRE 1.33
- SSYS 0.45
- MACD
- SYRE -0.26
- SSYS -0.18
- Stochastic Oscillator
- SYRE 67.01
- SSYS 0.85
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.